UPDF AI

The intestinal microbiota fuelling metabolic inflammation

H. Tilg,N. Zmora,T. Adolph,E. Elinav

2019 · DOI: 10.1038/s41577-019-0198-4
Nature reviews. Immunology · 762 件の引用

TLDR

The authors describe how metabolic disorders, such as type 2 diabetes and nonalcoholic fatty liver disease, are driven by alterations in the composition of the intestinal microbiota and its metabolites, which translocate from the gut across a disrupted intestinal barrier and contribute to metabolic inflammation.